Background: Diabetic nephropathy is a major challenge of diabetes mellitus, leading to significant morbidityand mortality. Raised serum uric acid (SUA) tier is a potential cause of deterioration of kidney disease, such asdiabetic nephropathy.Anthropometric measuresfor instance Body MassIndex (BMI) and waist circumference(WC) are crucial markers of adiposity, which is intimately linked to both progression of diabetic nephropathyand hyperuricemia. Objective: To evaluate the relation between SUAand anthropometric measures in diabetic nephropathy.Methods: Across-sectional study was executed involving 150 patients by convenience sampling diagnosedwith diabetic nephropathy at the Diabetic Clinic of Tertiary care Hospital in Lahore. SUAlevels were measuredusing enzymatic methods, while anthropometric measures, including BMI and waist circumference, wererecorded. The relation between SUA and these anthropometric measures was analyzed using Spearman correlation coefficient. Results: The median (IQR) SUA in diabetic nephropathy patients was 6.9 (5.4-8.6) mg/dl and in healthygroup was 5.2 (4.6-6.2) mg/dl. In diabetic nephropathy group, a significant direct relation of SUAwas foundwith BMI (rho = 0.296, p < 0.001) and also with waist circumference (rho = 0.435, p < 0.001). In healthy group,significant directrelationwasfoundwithwaist circumference only (rho=0.212, p=0.001).SUA,Waist circumference and BMI were higher considerably in diabetic nephropathy when measured against the control. Conclusion: The study demonstrates a significant relationship between elevated SUA levels and adverseanthropometric measures in diabetic nephropathy patients. These findings suggest that managing obesitythrough lifestyle modifications and pharmacotherapy could play a critical role in controlling SUA andpotentially slowing the progression of diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
Imran et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: